Tiziana Life Sciences (TLSA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tiziana Life Sciences is set to offer up to $10 million in common shares, as confirmed by their Bermuda counsel. The shares will be issued under a securities purchase agreement and are declared validly issued and fully paid. This move could present an intriguing opportunity for investors keeping an eye on the biotech sector.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.